Prescription drug · NDA AUTHORIZED GENERIC
Prednisolone Acetate NDC 68071-2222
Prednisolone acetate 10 mg/mL · Suspension/ drops · Ophthalmic · NuCare Pharmaceuticals,Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68071-2222-5 | 68071222205 | 1 BOTTLE, DROPPER in 1 CARTON (68071-2222-5) / 5 mL in 1 BOTTLE, DROPPERMarketed from Jul 27, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Prednisolone Acetate
- Generic name (nonproprietary)
- prednisolone acetate
- Active ingredients
- Prednisolone acetate — 10 mg/mL
- Dosage form
- Suspension/ drops
- Route
- Ophthalmic
- Labeler
- NuCare Pharmaceuticals,Inc.
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 017011
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 68071-2222_1d7617a8-dae4-7892-e063-6294a90a3f9fSPL ID 1d7617a8-dae4-7892-e063-6294a90a3f9fSPL set ID ab72cf3d-7660-41b1-e053-2995a90a7f44RxCUI 1376336UNII 8B2807733DUPC 0368071222258
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468071222205followed by a unit qualifier and the quantityPackage 68071-2222-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Prednisolone acetate ophthalmic suspension 1% is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 017011
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Prednisolone Acetate | Prednisolone acetate 10 mg/mL | Suspension/ dropsOphthalmic | Asclemed USA, Inc. | 76420-204 |
| Prednisolone Acetate | Prednisolone acetate 10 mg/mL | Suspension/ dropsOphthalmic | A-S Medication Solutions | 50090-1912 |
| Prednisolone Acetate | Prednisolone acetate 10 mg/mL | Suspension/ dropsOphthalmic | A-S Medication Solutions | 50090-5275 |
| Prednisolone Acetate | Prednisolone acetate 10 mg/mL | Suspension/ dropsOphthalmic | Sportpharm LLC | 85766-124 |
| Prednisolone Acetate | Prednisolone acetate 10 mg/mL | Suspension/ dropsOphthalmic | Pacific Pharma, Inc. | 60758-119 |
| Pred Forteprednisolone acetate | Prednisolone acetate 10 mg/mL | Suspension/ dropsOphthalmic | Allergan, Inc. | 11980-180 |